Canberra Corporation is excited to announce the launch of Husky® 845 Peroxall TB, a ready-to-use disinfectant formulated with hydrogen peroxide. Built with proprietary HydrOx+ Technology, this one-step hospital disinfectant is effective against a broad spectrum of bacteria and viruses, including Mycobacterium bovis (TB), Norovirus, MRSA, and SARS-CoV-2, with a 1-minute contact time on hard, non-porous surfaces.
Designed for everyday disinfecting and cleaning, Peroxall TB is suitable for use in healthcare, long-term care, educational, veterinary, and commercial settings. With a signal word of Caution (Toxicity Category III), it offers powerful efficacy with a lower toxicity classification than many traditional disinfectants. No dilution or mixing required, just spray and wipe.
“Peroxall TB reflects our commitment to safer, more effective disinfection,” said Courtney Ryan, Director of Marketing – I&I Division. “It delivers the performance facilities need with the simplicity and safety they want.”
Canberra Corporation is a recognized leader in cleaning chemical manufacturing, product innovation, and customer-driven services for the commercial, institutional, industrial, and retail markets.
